Skip to main content
Terug
AGESY logo

ageas SA/NV

Datakwaliteit: 100%
AGESY
OTC Financial Services Insurance - Diversified
€ 69,03
▲ € 1,27 (1,87%)
Marktkapitalisatie: 13,18B
Ook genoteerd als AGESF OTC
Dagbereik
€ 68,58 € 69,80
52-Weeksbereik
€ 53,88 € 75,43
Volume
789
50D / 200D Gem.
€ 71,43 / € 69,12
Vorige Slotkoers
€ 67,76

Koershistorie

Financiële Trends

Sectorvergelijking

vs Financial Services sector mediaan (854 peers)

Metriek Aandeel Sector Mediaan
P/E 8,0 10,3
P/B 1,7 1,1
ROE % 21,7 11,7
Net Margin % 8,7 16,8
Rev Growth 5Y % 9,9 11,7
D/E 0,6 0,5

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2029 € 12,35
€ 9,80 – € 14,89
 22 B 1
FY2028 € 11,01
€ 8,74 – € 13,28
 9,8 B 1
FY2027 € 10,27
€ 10,01 – € 10,51
 9,7 B 1

Belangrijkste Punten

Revenue grew 9,92% annually over 5 years — modest growth
Earnings grew 47,09% over the past year
ROE of 21,67% indicates high profitability
Generating 642,00M in free cash flow
P/E of 8,02 — trading at a low valuation
PEG of 0,16 suggests growth is underpriced

Groei

Revenue Growth (5Y)
9,92%
Revenue (1Y)122,29%
Earnings (1Y)47,09%
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
21,67%
ROIC0,00%
Net Margin8,72%
Op. Margin0,00%

Veiligheid

Debt / Equity
0,61
Current RatioN/A
Interest Coverage0,00

Waardering

P/E Ratio
8,02
P/B Ratio1,70
EV/EBITDAN/A
Dividend Yield0,05%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 122,29% Revenue Growth (3Y) 54,66%
Earnings Growth (1Y) 47,09% Earnings Growth (3Y) 31,36%
Revenue Growth (5Y) 9,92% Earnings Growth (5Y) 18,11%
Profitability
Revenue (TTM) 18,85B Net Income (TTM) 1,64B
ROE 21,67% ROA 1,67%
Gross Margin 100,00% Operating Margin 0,00%
Net Margin 8,72% Free Cash Flow (TTM) 642,00M
ROIC 0,00% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,61 Current Ratio N/A
Interest Coverage 0,00 Dividend Yield 0,05%
Valuation
P/E Ratio 8,02 P/B Ratio 1,70
P/S Ratio 0,70 PEG Ratio 0,16
EV/EBITDA N/A Dividend Yield 0,05%
Market Cap 13,18B Enterprise Value 15,86B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 18,85B 8,48B 7,88B 4,89B 12,91B
Net Income 1,64B 1,12B 953,00M 1,10B 845,00M
EPS (Diluted) 8,75 6,09 5,18 5,95 4,52
Gross Profit 18,85B 8,48B 6,94B 2,82B 11,69B
Operating Income 0,0 1,58B 1,43B 1,49B 1,23B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 98,46B 96,69B 100,30B 111,14B 111,42B
Total Liabilities 89,66B 88,19B 91,67B 96,97B 97,64B
Shareholders' Equity 7,75B 7,42B 6,98B 11,91B 11,56B
Total Debt 4,75B 4,59B 4,44B 4,73B 4,71B
Cash & Equivalents 2,08B 1,88B 1,15B 1,94B 2,24B
Current Assets 2,14B 58,78B 42,14B 57,19B 61,22B
Current Liabilities 0,0 520,00M 704,00M 723,00M 801,00M

Strategiescores

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Growth Price/Sales Ratio Focus (Ken Fisher)
#25 of 616
87
Custom Contrarian Investing (David Dreman)
#222 of 658
42

Recente Activiteit

Ingestapt Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Ingestapt Contrarian Investing (David Dreman)
Mar 24, 2026